Although H1-25 EBITDA missed expectations, top line growth trends are encouraging and more operational leverage will be kicking in in H2-25. Belgium has turned the corner and there is a rise in the interim dividend. Although there is a bit of delay, we confirm our investment case as outlined in our recent in-depth report called ‘Ready for the market recovery'. We reiterate our Buy and TP of EUR 16.5
